Dr Srikanth Muralikrishnan is a Senior Consultant, Hemato Oncology at Apollo Cancer Centre, Chennai. He has had extensive research experience in drug development of Multiple Myeloma & Pioneer Phase I & II trails of extensively Multiple Myeloma. He has been awarded MD (Research) by the prestigious Institute of cancer research at UK in partnership with Royal Mas Hospital, UK. He is also the recipient of the prestigious award of GCRS where in Royal Ma Hospital, UK.